RK

Rajeev Kumar

Active Director Director DIN 10773159
DIN 10773159 First appointment Sep 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value •••• Premium profile

About Rajeev Kumar

Data last updated:

Rajeev Kumar is a Director at Curebion Life Science Private Limited (since 2024). Curebion Life Science Private Limited reported revenue of ₹15.53 Cr (FY 2025).

DIN 10773159
Primary Designation Director
First Appointment 09 Sep 2024
Oldest Company Age 2 yrs
Largest company Curebion Life Science Private Limited · ₹15.53 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Sep 20242024₹15.53 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Curebion Life Science Private Limited
Premium access

Shareholding and investment profile for Rajeev Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeev Kumar

Rajeev Kumar currently holds 1 directorship: Curebion Life Science Private Limited (Director, since 09 Sep 2024, revenue ₹15.53 Cr (FY 2025)).

Rajeev Kumar was first appointed on 09 Sep 2024 as Director at Curebion Life Science Private Limited.

The current boards of Rajeev Kumar's companies include Gopal Shankar Prasad (Curebion Life Science Private Limited), Jiwan Kumar (Curebion Life Science Private Limited), Neeraj Kumar (Curebion Life Science Private Limited), Ravi Ranjan Gupta (Curebion Life Science Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available